| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Division of Nephrology,*
IRCCS Policlinico San
Matteo, University of Pavia, Pavia, Italy, Renal Cell Biology
Laboratory,
Department of Medicine, University
of Miami School of Medicine, Miami, Florida, and Division of Basic
Medical Sciences,
Mercer University, School
of Medicine, Macon, Georgia
Nephron reduction is an important factor in the development of glomerulosclerosis. In a study of the oligosyndactyly (Os) mutation that causes a congenital 50% reduction in nephron number, we previously found that ROP Os/+ mice developed glomerulosclerosis whereas C57B1/6J Os/+ mice did not. We concluded that the predisposition to glomerulosclerosis depended largely on the genetic background, the ROP being sclerosis-prone whereas the C57 strain was sclerosis-resistant. In the current experiments we asked whether the intensity of the sclerotic response to nephron reduction in the ROP strain was related to the time at which it occurred, ie, a pre- or post-natal event. We also determined whether the absence of lesions in C57 Os/+ mice was caused by a higher threshold for the induction of a sclerotic response in C57 mice. We further examined the relationship between glomerular hypertrophy and sclerosis. C57 +/+, C57 Os/+, ROP +/+, and ROP Os/+ mice were uninephrectomized (NX) at age 10 weeks and followed for 8 weeks. We found no sclerotic changes in NX C57 +/+ and C57 Os/+ mice, despite a 75% reduction in nephron number in the latter. In contrast, both NX ROP +/+ and NX ROP Os/+ mice had glomerulosclerosis, which was more severe in the NX ROP Os/+ mice. Examination of extracellular matrix synthesis and degradation at the mRNA level revealed that synthesis exceeded degradation in ROP Os/+ mice. The lesions in NX ROP +/+ were less severe than in sham-operated ROP/Os mice, suggesting that the timing of nephron reduction affected the amplitude of the sclerotic response in this strain. Following NX, an increase in glomerular volume was found in C57 +/+, ROP +/+, and ROP Os/+ mice. However, NX did not lead to a further increase in glomerular volume in C57 Os/+ mice. We make three conclusions: 1) sclerosis was more severe in the ROP strain when nephron reduction occurred in utero; 2) the absence of glomerulosclerosis in C57 mice was not related to a higher threshold for a sclerosis response in this strain; and 3) whereas glomerular size continued to increase as nephron number decreased in ROP mice, it reached a plateau in C57 mice.
This article has been cited by other articles:
 |
|
 |
|
  M. L. Weber, M. Farooqui, J. Nguyen, M. Ansonoff, J. E. Pintar, R. P. Hebbel, and K. Gupta Morphine induces mesangial cell proliferation and glomerulopathy via {kappa}-opioid receptors Am J Physiol Renal Physiol, June 1, 2008; 294(6): F1388 - F1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Inada, K. Nagai, H. Arai, J.-i. Miyazaki, K. Nomura, H. Kanamori, S. Toyokuni, Y. Yamada, S. Bonner-Weir, G. C. Weir, et al. Establishment of a Diabetic Mouse Model with Progressive Diabetic Nephropathy Am. J. Pathol., August 1, 2005; 167(2): 327 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-K. Chen, J. Chen, E. G. Neilson, and R. C. Harris Role of Mammalian Target of Rapamycin Signaling in Compensatory Renal Hypertrophy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1384 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC Mouse Models of Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Roselli, L. Heidet, M. Sich, A. Henger, M. Kretzler, M.-C. Gubler, and C. Antignac Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice Mol. Cell. Biol., January 15, 2004; 24(2): 550 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Elliot, M. Karl, M. Berho, M. Potier, F. Zheng, B. Leclercq, G. E. Striker, and L. J. Striker Estrogen Deficiency Accelerates Progression of Glomerulosclerosis in Susceptible Mice Am. J. Pathol., May 1, 2003; 162(5): 1441 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zheng, A. R. Plati, M. Potier, Y. Schulman, M. Berho, A. Banerjee, B. Leclercq, A. Zisman, L. J. Striker, and G. E. Striker Resistance to Glomerulosclerosis in B6 Mice Disappears after Menopause Am. J. Pathol., April 1, 2003; 162(4): 1339 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fornoni, Y. Wang, O. Lenz, L. J. Striker, and G. E. Striker Association of a Decreased Number of d(CA) Repeats in the Matrix Metalloproteinase-9 Promoter with Glomerulosclerosis Susceptibility in Mice J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2068 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pillebout, M. Burtin, H. T. Yuan, P. Briand, A. S. Woolf, G. Friedlander, and F. Terzi Proliferation and Remodeling of the Peritubular Microcirculation after Nephron Reduction : Association with the Progression of Renal Lesions Am. J. Pathol., August 1, 2001; 159(2): 547 - 560. [Abstract] [Full Text]
|
|
|
|
|
|
F. TERZI, M. BURTIN, and G. FRIEDLANDER Using Transgenic Mice to Analyze the Mechanisms of Progression of Chronic Renal Failure J. Am. Soc. Nephrol., November 1, 2000; 11(90002): 144S - 148. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. El-Meanawy, J. R. Schelling, F. Pozuelo, M. M. Churpek, E. K. Ficker, S. Iyengar, and J. R. Sedor Use of serial analysis of gene expression to generate kidney expression libraries Am J Physiol Renal Physiol, August 1, 2000; 279(2): F383 - F392. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
